As part of the DCAT Member Company Announcement Forum, held on March 21, 2022, at DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT), DCAT invited its Member Companies to submit major news announcements from their companies of significance to the bio/pharmaceutical manufacturing value chain. The news could cover manufacturing expansions, mergers and acquisitions (M&A), including post-M&A integration, or other key corporate developments with the announcements or related projects in the announcement occurring in 2022 and beyond.

CEOs and senior executives from 12 DCAT Member Companies were selected to outline their news at the DCAT Member Company Announcement Forum on March 21, 2022. Applications for podium time at DCAT Week were reviewed by the DCAT Member Company Announcement Forum Oversight Committee, and companies were selected on the basis of the news (i.e., investment amounts) and relevance to DCAT Member Companies. Given time limits in the two-hour program, all DCAT Member Companies were given the opportunity to share news as part of this special edition of DCAT Value Chain Insights that highlights news from DCAT Week.

The news submitted from companies involved in the development and manufacturing of chemicals and small-molecule active pharmaceutical ingredients (APIs) are outlined here (featuring news from Aceto, Cerbios-Pharma, ChemCon, Flamma, Formosa Laboratories, Novasep, Olon, Procos, Porton, Sai Life Sciences, and Seqens), and from companies involved in formulation development, drug-product manufacturing, and packaging here (featuring news from Adare Pharma, ACG, BSP Pharmaceuticals, Bushu Pharma, Datwyler, Delpharm, DFE Pharma, DFE Pharma, Sterling & Harro Höfliger (group announcement), Grand River Aseptic Manufacturing, Nanoform, Roquette, and Stevanato).

A roundup of the 12 announcements from the DCAT Member Company Announcement Forum from DCAT Week may be found here (featuring news from, AGC Biologics, Cambrex, Catalent, CordenPharma, Cytiva, HAS Healthcare Advanced Synthesis, IDT Biologika, Lonza, Samsung Biologics, Selkirk Pharma, Thermo Fisher Scientific, and WuXi STA).